PubRank

Yasuhito Hamaguchi

Author PubWeight™ 61.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med 2004 3.56
2 Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol 2008 2.45
3 B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J Immunol 2007 2.05
4 B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol 2008 1.96
5 B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 2006 1.64
6 CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest 2002 1.61
7 Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 2012 1.56
8 Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV. Blood 2008 1.55
9 Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis. Rheumatology (Oxford) 2010 1.46
10 IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease. J Invest Dermatol 2012 1.26
11 The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford) 2012 1.20
12 Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease. Proc Natl Acad Sci U S A 2005 1.15
13 Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? J Dermatol Sci 2008 1.11
14 Association between nail-fold capillary findings and disease activity in dermatomyositis. Rheumatology (Oxford) 2011 1.10
15 Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol 2006 1.09
16 L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity. J Immunol 2003 1.09
17 Host-derived MCP-1 and MIP-1α regulate protective anti-tumor immunity to localized and metastatic B16 melanoma. Am J Pathol 2011 1.09
18 Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis 2012 1.04
19 Potential roles of interleukin-17A in the development of skin fibrosis in mice. Arthritis Rheum 2012 1.02
20 Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis. Clin Rheumatol 2010 1.01
21 Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood 2013 0.99
22 Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol 2007 0.98
23 Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis. Rheumatology (Oxford) 2009 0.95
24 CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol 2010 0.94
25 Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1. J Leukoc Biol 2007 0.94
26 Sequentially appearing erythema nodosum, erythema multiforme and Henoch-Schönlein purpura in a patient with Mycoplasma pneumoniae infection: a case report. J Med Case Rep 2012 0.93
27 The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expression. J Immunol 2002 0.92
28 Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis. J Neuroimmunol 2005 0.92
29 Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis. Clin Rheumatol 2012 0.91
30 E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis. Am J Pathol 2006 0.90
31 B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol 2013 0.89
32 Adult-onset Still's disease with dermatomyositis-like eruption. J Dermatol 2012 0.89
33 Drug-induced hypersensitivity syndrome associated with human herpesvirus 6 and cytomegalovirus reactivation. J Dermatol 2005 0.88
34 Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. Arthritis Care Res (Hoboken) 2014 0.86
35 Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway. Arthritis Rheum 2010 0.84
36 Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis. J Dermatol Sci 2012 0.84
37 Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis. J Dermatol Sci 2005 0.83
38 Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production. Am J Pathol 2011 0.83
39 High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis. Mod Rheumatol 2012 0.83
40 Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica. Dermatol Surg 2004 0.82
41 Clinical and laboratory features dependent on age at onset in Japanese systemic sclerosis. Mod Rheumatol 2012 0.82
42 FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin. Arthritis Rheum 2013 0.80
43 Dermokine inhibits ELR(+)CXC chemokine expression and delays early skin wound healing. J Dermatol Sci 2013 0.80
44 Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis. J Rheumatol 2011 0.80
45 The efficacy of self-administered stretching for finger joint motion in Japanese patients with systemic sclerosis. J Rheumatol 2006 0.80
46 Ultraviolet light exposure suppresses contact hypersensitivity by abrogating endothelial intercellular adhesion molecule-1 up-regulation at the elicitation site. J Immunol 2003 0.79
47 Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts. J Dermatol Sci 2012 0.79
48 Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis 2012 0.79
49 Basophils and mast cells play critical roles for leukocyte recruitment in IgE-mediated cutaneous reverse passive Arthus reaction. J Dermatol Sci 2012 0.78
50 Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease. J Dermatol 2014 0.78
51 Case report of anti-transcription intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor. J Dermatol 2013 0.78
52 Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodies. Rheumatol Int 2007 0.77
53 Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis. J Dermatol 2012 0.77
54 Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis. Mod Rheumatol 2014 0.77
55 Investigations of IgG4-related disease involving the skin. Mod Rheumatol 2012 0.76
56 Accumulation of mature B cells in the inflamed muscle tissue of a patient with anti-155/140 antibody-positive juvenile dermatomyositis. Mod Rheumatol 2012 0.76
57 Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases. Mod Rheumatol 2012 0.76
58 A crucial role of L-selectin in C protein-induced experimental polymyositis in mice. Arthritis Rheumatol 2014 0.75
59 Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis. Rheumatology (Oxford) 2012 0.75
60 An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitial Lung Disease in a Patient with Three Deteriorations in 9 years. Intern Med 2017 0.75
61 Clinical association of serum CD137 (4-1BB) levels in patients with systemic sclerosis. J Dermatol Sci 2008 0.75
62 TIF1γ-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody. Acta Derm Venereol 2013 0.75
63 The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients. Mod Rheumatol 2014 0.75
64 A case of anti-nuclear matrix protein 2 antibody positive myopathy associated with lung cancer. Rinsho Shinkeigaku 2016 0.75
65 [A case of amyopathic dermatomyositis with acute interstitial pneumonia (DAD pattern)]. Nihon Rinsho Meneki Gakkai Kaishi 2004 0.75
66 Neuro-Sweet disease mimicking recurrent anaplastic astrocytoma associated with therapy-related myelodysplastic syndrome: a case report. Clin Neurol Neurosurg 2012 0.75
67 Pemphigus foliaceus associated with anti-NXP2 autoantibody-positive dermatomyositis. Acta Derm Venereol 2014 0.75
68 The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients. Mod Rheumatol 2013 0.75
69 Skin sclerosis as a manifestation of POEMS syndrome. J Dermatol 2012 0.75
70 Increased expression of epidermal thymic stromal lymphopoietin in inflammatory peeling skin syndrome. J Dermatol 2014 0.75
71 Anti-SRP antibody-positive myopathy with universal alopecia and multiple vitiligo. Acta Derm Venereol 2015 0.75
72 Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension. J Dermatol Sci 2009 0.75
73 Two young-adult female cases of dermatomyositis with antibodies for transcriptional intermediary factor 1-γ. Eur J Dermatol 2012 0.75
74 Two cases of livedo vasculopathy with non-criteria antiphospholipid antibodies. J Dermatol 2012 0.75
75 Fatal case of clinically amyopathic dermatomyositis: cotton-wool spots as a sign of an aggressive subtype of dermatomyositis. J Dermatol 2014 0.75